Leukemia Clinical Trials

Showing 6461-6480 of 8,366 trials

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

NCT00288340

The goal of the project is to characterize abnormalities in brain structure and function related to schizophrenia. The investigators will use advanced magnetic resonance imaging (MRI) techniques to measure the degree and distribution of neuronal activity during specific cognitive tasks, alterations in neuronal connectivity, and how these are related to disease symptoms and treatment.

SchizophreniaSchizoaffective DisorderHallucinations

Vanderbilt University60 participantsStarted Jan 2006

Nashville, Tennessee, United States

COMPLETEDNA

Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)

NCT02043002

Erlotinib, an anti-cancer agent targeting the epidermal growth factor receptor (EGFR), is an active treatment of patients with non-small cell lung cancer (NSCLC). Effect of treatment is primary seen in patients harboring a mutation in the EGFR. However, 10-15% of patients does not harbor a mutation but respond as well. Identifying these patients is a problem and methods are lacking. Studies have shown that an early 18F FDG-PET might can predict response and outcome in these patients, but further studies are needed to confirm these findings.

Non-small Cell Lung Cancer Patients

University of Aarhus67 participantsStarted Apr 2013

Aarhus, Jylland, Denmark

COMPLETEDPhase 2

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

NCT01160601

This is a randomized, open-label, multicenter, phase 2 study comparing Paclitaxel/Carboplatin with or without bavituximab in patients that have previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC).

Non-Squamous Non-Small Cell Lung Cancer

Peregrine Pharmaceuticals86 participantsStarted Jun 2010

Chandler, Arizona, United States • Jonesboro, Arkansas, United States • Whittier, California, United States +37 more locations

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

Related Searches

Sonosalpingography After Hysteroscopic Tubal Occlusion

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects

A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations

Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy

B7.1/IL-2 Leukaemia Cell Vaccine for Non-Transplant AML RFUSIN2-AML2 (NTX)

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy

Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients

Study of Re-operation Rate After Introduction of Evidence Based Algorithm for the Treatment of Ankle Fractures

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

The Permacol Dutch Cohort Study

Prospective Study of Non-operative Management of SBO Without Nasogastric Tube Placement

MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC